{
 "as_of": "2026-11-06",
 "cmr": "uk-cm-kg/LSE/SVNS",
 "fence": "The page is the record's research on the issuer — no analyst, no rating, no view.",
 "markdown": "The page is the record's research on the issuer — no analyst, no rating, no view.\n\n# SOLVONIS THERAPEUTICS PLC (LSE Main Market: SVNS) — research page\n\nAs of 2026-11-06 · uk-cm-kg · record version 1\n\n## Identity and listing\n\nSOLVONIS THERAPEUTICS PLC is listed on the LSE Main Market under ticker SVNS, ISIN GB00BMD1Z199, LEI 2138005PH7OJRCRPUD88. Its security type is Corporate and its segment is SSQ3. Its sector is Pharmaceuticals and Biotechnology [201030] and its jurisdiction is England and Wales (Companies House jurisdiction field). Its listing status is listed, not halted.\n\n## The disclosure read\n\nThe record holds 32 filings in the twelve months from 2025-11-06 to 2026-11-06, on 32 filing days. The median gap between filing days is 9 days. The latest filing is dated 2026-11-06, 0 days before the record date, and is a newswire release. On the LSE Main Market the median cadence gap is 4 days, the median filings count is 29.0 and the median latency is 3 days, across 892 issuers. In the sector the median cadence gap is 6.0 days, the median filings count is 42 and the median latency is 4.0 days, across 51 issuers. The issuer's 32 filings sit above the exchange median of 29.0 and below the sector median of 42. Its cadence gap of 9 days sits above both medians. Its latency of 0 days sits below both medians.\n\n## Auditor\n\nThe auditor of record is Kreston Reeves LLP. Its location is not on the record. Auditor changes are not on the record.\n\n## Events and halts\n\nListing, delisting, name change, domicile change and segment move are not on the record, because no lifecycle type map exists for this register yet. The halt flag is listed, not halted.\n\n## Orderability\n\nFor elective professional client, the outcome is signal ACM-200, determinable. For eligible counterparty, the outcome is signal ACM-200, determinable. The rule version is acm-68000/uk/product-governance-fca-prod-sourcebook/r1, and the chapter is as of 2026-11-04.\n\n## Coverage\n\nThe issuer's investor-relations page names 3 research houses: Singer Capital Markets, Water Tower Research and Turner Pope Investments (TPI) Limited.\n\n## Open research\n\nThe record holds 1 openly published research note: Water Tower Research, dated 2026-07-13.\n\n## Licensed\n\nLicensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded.\n\n## As-of depth\n\nNo years are sealed for this issuer, and the market's vintage is not sealed. The market has no earliest sealed date. The live record began on 2026-09-11. Years 2021 through 2026 are sealed in the store but not served as of a date, and the as-of door answers not_sealed.\n\n## Sources\n\n12 source pages are named on this page; every value above carries its own source page and read date in the numbers.\n\n- https://www.londonstockexchange.com/live-markets/market-data-dashboard/price-explorer (identity.exchange)\n- https://api.londonstockexchange.com/api/gw/lse/instruments/alldata/SVNS (identity.isin)\n- https://find-and-update.company-information.service.gov.uk/company/10776788 (identity.jurisdiction)\n- https://mapping.gleif.org/api/v2/isin-lei/latest/download (identity.lei)\n- https://www.londonstockexchange.com/stock/SVNS/solvonis-therapeutics-plc/company-page (identity.sector)\n- https://mcp.uk-cm-kg.ai/events/LSE/SVNS (the disclosure lines)\n- https://marketsecurities.fca.org.uk/officiallist (the halt flag)\n- https://find-and-update.company-information.service.gov.uk/company/10776788/filing-history/MzUyMzcxNjc5NWFkaXF6a2N4/document?format=pdf&download=0 (the auditor)\n- https://mcp.uk-cm-kg.ai/book/aio.json (the orderability chapter)\n- https://solvonis.com/investor-relations/analyst-coverage (coverage)\n- https://cdn.smartinsider.com/InternalAnnouncement/pdf/2026/07/13/47627131.pdf (open research)\n- https://mcp.uk-cm-kg.ai/record/LSE/SVNS (the record)\n",
 "market": "UK",
 "node": "uk-cm-kg",
 "numbers": {
  "as_of_depth": {
   "issuer_years_sealed": [],
   "live_record_began": "2026-09-11",
   "node_history_from": null,
   "node_years_sealed": [],
   "note": "6 years are sealed in the UK store; their Replay split is not built, so the as-of door answers not_sealed and the record is the live record as of 2026-11-06",
   "record_version": 1,
   "sealed": false,
   "store_years_sealed_not_served": [
    "2021",
    "2022",
    "2023",
    "2024",
    "2025",
    "2026"
   ]
  },
  "auditor": {
   "auditor": {
    "read_by": "read by ChatGPT (batch)",
    "read_date": "2026-11-06",
    "read_date_basis": "the record version as_of",
    "source": "https://find-and-update.company-information.service.gov.uk/company/10776788/filing-history/MzUyMzcxNjc5NWFkaXF6a2N4/document?format=pdf&download=0",
    "state": "filled",
    "value": "Kreston Reeves LLP"
   },
   "auditor_firm_id": {
    "market": "UK",
    "state": "not_on_record"
   },
   "auditor_location": {
    "market": "UK",
    "state": "not_on_record"
   },
   "changes": {
    "market": "UK",
    "reason": "no lifecycle type map for this register yet (SHELF-01: us and ca first)",
    "state": "not_on_record"
   }
  },
  "cmr": "uk-cm-kg/LSE/SVNS",
  "coverage": {
   "count": 3,
   "houses": [
    {
     "house": "Singer Capital Markets",
     "read_by": "issuer IR page, fetched by this rail; each house name read on the page",
     "read_date": "2026-11-12",
     "source": "https://solvonis.com/investor-relations/analyst-coverage",
     "state": "sourced"
    },
    {
     "house": "Water Tower Research",
     "read_by": "issuer IR page, fetched by this rail; each house name read on the page",
     "read_date": "2026-11-12",
     "source": "https://solvonis.com/investor-relations/analyst-coverage",
     "state": "sourced"
    },
    {
     "house": "Turner Pope Investments (TPI) Limited",
     "read_by": "issuer IR page, fetched by this rail; each house name read on the page",
     "read_date": "2026-11-12",
     "source": "https://solvonis.com/investor-relations/analyst-coverage",
     "state": "sourced"
    }
   ],
   "pages_checked": [
    {
     "page": "https://solvonis.com/investor-relations/analyst-coverage",
     "result": "read: 3 of 5 named houses found on the page"
    },
    {
     "page": "https://www.research-tree.com/Download/lse/1821f81f-5e7a-4f88-8014-cc7949b0861d",
     "result": "not readable by this rail (403)"
    }
   ],
   "read_by": "Perplexity sonar (search) · page read by this rail",
   "read_date": "2026-11-12",
   "since": "not stated on the page read",
   "state": "found"
  },
  "disclosure": {
   "against": {
    "exchange": {
     "issuers": 892,
     "median_cadence_gap_days": 4,
     "median_filings": 29,
     "median_latency_days": 3,
     "name": "LSE Main Market"
    },
    "sector": {
     "issuers": 51,
     "median_cadence_gap_days": 6,
     "median_filings": 42,
     "median_latency_days": 4,
     "name": "Pharmaceuticals and Biotechnology [201030]"
    }
   },
   "by_type": {
    "agm_record_date": 2,
    "ch_accounts_filed": 1,
    "ch_capital": 2,
    "ch_confirmation_statement": 1,
    "ch_officer_change": 2,
    "ch_resolution": 1,
    "director_dealing": 1,
    "early_warning": 1,
    "financial_statement": 1,
    "newswire_release": 1,
    "regulatory_announcement": 19
   },
   "cadence_median_gap_days": 9,
   "filing_days": 32,
   "filings": 32,
   "latency_days": 0,
   "latest": [
    {
     "category": null,
     "date": "2026-11-06",
     "source": "https://www.newsfilecorp.com/release/322692/Solvonis-Therapeutics-plc-Announces-US-Patent-Office-Allows-Ketamine-Patent-Across-All-Behavioural-Addictions",
     "title": "Solvonis Therapeutics plc Announces US Patent Office Allows Ketamine Patent Across All Behavioural Addictions",
     "type": "newswire_release"
    },
    {
     "category": null,
     "date": "2026-11-05",
     "source": "https://www.investegate.co.uk/announcement/rns/solvonis-therapeutics-plc--svns/us-patent-office-allows-ketamine-patent/9859164",
     "title": "US Patent Office allows ketamine patent",
     "type": "regulatory_announcement"
    },
    {
     "category": null,
     "date": "2026-10-30",
     "source": "https://www.investegate.co.uk/announcement/rns/solvonis-therapeutics-plc--svns/directorate-change/9849243",
     "title": "Directorate change",
     "type": "director_dealing"
    },
    {
     "category": null,
     "date": "2026-10-16",
     "source": "https://www.investegate.co.uk/announcement/rns/solvonis-therapeutics-plc--svns/holding-s-in-company/9827316",
     "title": "Holding(s) in Company",
     "type": "early_warning"
    },
    {
     "category": null,
     "date": "2026-10-13",
     "source": "https://www.investegate.co.uk/announcement/rns/solvonis-therapeutics-plc--svns/mou-reached-with-icad/9819104",
     "title": "MOU Reached with ICAD",
     "type": "regulatory_announcement"
    }
   ],
   "latest_filing_date": "2026-11-06",
   "read": "the node's event lines (list_events_since), as get_filings serves them",
   "source": "https://mcp.uk-cm-kg.ai/events/LSE/SVNS",
   "window": {
    "from": "2025-11-06",
    "to": "2026-11-06"
   }
  },
  "identity": {
   "exchange": {
    "read_by": "LSE price explorer (exchange list)",
    "read_date": "2026-11-06",
    "read_date_basis": "the record version as_of",
    "source": "https://www.londonstockexchange.com/live-markets/market-data-dashboard/price-explorer (price-explorer feed api.londonstockexchange.com/api/v1/components/refresh, markets=MAINMARKET, categories=EQUITY, showonlylse=true)",
    "state": "sourced",
    "value": "LSE Main Market"
   },
   "isin": {
    "read_by": "LSE instrument reference record (exchange site)",
    "read_date": "2026-11-06",
    "read_date_basis": "the record version as_of",
    "source": "https://api.londonstockexchange.com/api/gw/lse/instruments/alldata/SVNS",
    "state": "confirmed",
    "value": "GB00BMD1Z199"
   },
   "jurisdiction": {
    "read_by": "Companies House REST API (company profile) (jurisdiction field)",
    "read_date": "2026-11-06",
    "read_date_basis": "the record version as_of",
    "source": "https://find-and-update.company-information.service.gov.uk/company/10776788",
    "state": "confirmed",
    "value": "England and Wales (Companies House jurisdiction field)"
   },
   "lei": {
    "read_by": "GLEIF ISIN-to-LEI mapping file (daily), LEI by exact ISIN",
    "read_date": "2026-11-09",
    "read_date_basis": "the field",
    "source": "https://mapping.gleif.org/api/v2/isin-lei/latest/download (ISIN GB00BMD1Z199)",
    "state": "sourced",
    "value": "2138005PH7OJRCRPUD88"
   },
   "name": {
    "read_by": "LSE price explorer (exchange list)",
    "read_date": "2026-11-06",
    "read_date_basis": "the record version as_of",
    "source": "https://www.londonstockexchange.com/live-markets/market-data-dashboard/price-explorer (price-explorer feed api.londonstockexchange.com/api/v1/components/refresh, markets=MAINMARKET, categories=EQUITY, showonlylse=true)",
    "state": "sourced",
    "value": "SOLVONIS THERAPEUTICS PLC"
   },
   "sector": {
    "read_by": "LSE issuer profile (exchange site)",
    "read_date": "2026-11-06",
    "read_date_basis": "the record version as_of",
    "source": "https://www.londonstockexchange.com/stock/SVNS/solvonis-therapeutics-plc/company-page",
    "state": "sourced",
    "value": "Pharmaceuticals and Biotechnology [201030]"
   },
   "security_type": {
    "read_by": "LSE price explorer (exchange list)",
    "read_date": "2026-11-06",
    "read_date_basis": "the record version as_of",
    "source": "https://www.londonstockexchange.com/live-markets/market-data-dashboard/price-explorer (price-explorer feed api.londonstockexchange.com/api/v1/components/refresh, markets=MAINMARKET, categories=EQUITY, showonlylse=true)",
    "state": "sourced",
    "value": "Corporate"
   },
   "segment": {
    "read_by": "LSE price explorer (exchange list)",
    "read_date": "2026-11-06",
    "read_date_basis": "the record version as_of",
    "source": "https://www.londonstockexchange.com/live-markets/market-data-dashboard/price-explorer (price-explorer feed api.londonstockexchange.com/api/v1/components/refresh, markets=MAINMARKET, categories=EQUITY, showonlylse=true)",
    "state": "sourced",
    "value": "SSQ3"
   },
   "ticker": {
    "read_by": "LSE price explorer (exchange list)",
    "read_date": "2026-11-06",
    "read_date_basis": "the record version as_of",
    "source": "https://www.londonstockexchange.com/live-markets/market-data-dashboard/price-explorer (price-explorer feed api.londonstockexchange.com/api/v1/components/refresh, markets=MAINMARKET, categories=EQUITY, showonlylse=true)",
    "state": "sourced",
    "value": "SVNS"
   },
   "website": {
    "read_by": "LSE issuer profile (exchange site)",
    "read_date": "2026-11-06",
    "read_date_basis": "the record version as_of",
    "source": "https://www.londonstockexchange.com/stock/SVNS/solvonis-therapeutics-plc/company-page",
    "state": "sourced",
    "value": "https://solvonis.com/"
   }
  },
  "licensed": {
   "columns": [
    "licensor",
    "entitlement",
    "title",
    "date",
    "source"
   ],
   "rows": [],
   "rule": "A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded."
  },
  "lifecycle": {
   "delisting": {
    "market": "UK",
    "reason": "no lifecycle type map for this register yet (SHELF-01: us and ca first)",
    "state": "not_on_record"
   },
   "domicile_change": {
    "market": "UK",
    "reason": "no lifecycle type map for this register yet (SHELF-01: us and ca first)",
    "state": "not_on_record"
   },
   "listing": {
    "market": "UK",
    "reason": "no lifecycle type map for this register yet (SHELF-01: us and ca first)",
    "state": "not_on_record"
   },
   "name_change": {
    "market": "UK",
    "reason": "no lifecycle type map for this register yet (SHELF-01: us and ca first)",
    "state": "not_on_record"
   },
   "segment_move": {
    "market": "UK",
    "reason": "no lifecycle type map for this register yet (SHELF-01: us and ca first)",
    "state": "not_on_record"
   }
  },
  "market": "UK",
  "node": "uk-cm-kg",
  "numbers_hash": "sha256:9e0e2cebc074c872489cb735fad6e8dee94c161a7a2a0cd1447b7e9571a91144",
  "open_research": {
   "read_date": "2026-11-12",
   "rows": [
    {
     "date": "2026-07-13",
     "kind": "issuer-sponsored",
     "publisher": "Water Tower Research",
     "read_by": "the note's link answers (200 application/pdf); a document, not read as text",
     "read_date": "2026-11-12",
     "source": "https://cdn.smartinsider.com/InternalAnnouncement/pdf/2026/07/13/47627131.pdf",
     "state": "sourced",
     "title": "SVNS: Pursuing Acute Intervention Rather Than Chronic Treatment of High-Burden CNS Conditions"
    }
   ],
   "state": "found"
  },
  "orderability": {
   "chapter_as_of": "2026-11-04",
   "client_categories": [
    "elective professional client",
    "eligible counterparty"
   ],
   "outcomes": {
    "elective professional client": {
     "determinable": true,
     "signal": "ACM-200"
    },
    "eligible counterparty": {
     "determinable": true,
     "signal": "ACM-200"
    }
   },
   "read": {
    "basis": "one live read per instrument class, halt state and client category on this market; this issuer's group",
    "chapter": "https://mcp.uk-cm-kg.ai/book/aio.json",
    "door": "https://mcp.uk-cm-kg.ai/mcp",
    "tool": "get_orderability"
   },
   "rule_version": "acm-68000/uk/product-governance-fca-prod-sourcebook/r1",
   "section": "uk.aio.v16"
  },
  "record": {
   "as_of": "2026-11-06",
   "url": "https://mcp.uk-cm-kg.ai/record/LSE/SVNS",
   "version": 1
  },
  "schema": "research-numbers v0.1 (USR-01, 2026-11-11)",
  "status": {
   "read_date": "2026-11-09",
   "source": "https://marketsecurities.fca.org.uk/officiallist",
   "value": "listed, not halted"
  }
 },
 "numbers_hash": "sha256:9e0e2cebc074c872489cb735fad6e8dee94c161a7a2a0cd1447b7e9571a91144",
 "path": "/uk/LSE/SVNS",
 "schema": "research-page v0.1 (USR-02, 2026-11-11)",
 "sections": [
  {
   "id": "identity",
   "text": "SOLVONIS THERAPEUTICS PLC is listed on the LSE Main Market under ticker SVNS, ISIN GB00BMD1Z199, LEI 2138005PH7OJRCRPUD88. Its security type is Corporate and its segment is SSQ3. Its sector is Pharmaceuticals and Biotechnology [201030] and its jurisdiction is England and Wales (Companies House jurisdiction field). Its listing status is listed, not halted.",
   "title": "Identity and listing"
  },
  {
   "id": "disclosure",
   "text": "The record holds 32 filings in the twelve months from 2025-11-06 to 2026-11-06, on 32 filing days. The median gap between filing days is 9 days. The latest filing is dated 2026-11-06, 0 days before the record date, and is a newswire release. On the LSE Main Market the median cadence gap is 4 days, the median filings count is 29.0 and the median latency is 3 days, across 892 issuers. In the sector the median cadence gap is 6.0 days, the median filings count is 42 and the median latency is 4.0 days, across 51 issuers. The issuer's 32 filings sit above the exchange median of 29.0 and below the sector median of 42. Its cadence gap of 9 days sits above both medians. Its latency of 0 days sits below both medians.",
   "title": "The disclosure read"
  },
  {
   "id": "auditor",
   "text": "The auditor of record is Kreston Reeves LLP. Its location is not on the record. Auditor changes are not on the record.",
   "title": "Auditor"
  },
  {
   "id": "events",
   "text": "Listing, delisting, name change, domicile change and segment move are not on the record, because no lifecycle type map exists for this register yet. The halt flag is listed, not halted.",
   "title": "Events and halts"
  },
  {
   "id": "orderability",
   "text": "For elective professional client, the outcome is signal ACM-200, determinable. For eligible counterparty, the outcome is signal ACM-200, determinable. The rule version is acm-68000/uk/product-governance-fca-prod-sourcebook/r1, and the chapter is as of 2026-11-04.",
   "title": "Orderability"
  },
  {
   "id": "coverage",
   "text": "The issuer's investor-relations page names 3 research houses: Singer Capital Markets, Water Tower Research and Turner Pope Investments (TPI) Limited.",
   "title": "Coverage"
  },
  {
   "id": "open_research",
   "text": "The record holds 1 openly published research note: Water Tower Research, dated 2026-07-13.",
   "title": "Open research"
  },
  {
   "id": "licensed",
   "text": "Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded.",
   "title": "Licensed"
  },
  {
   "id": "depth",
   "text": "No years are sealed for this issuer, and the market's vintage is not sealed. The market has no earliest sealed date. The live record began on 2026-09-11. Years 2021 through 2026 are sealed in the store but not served as of a date, and the as-of door answers not_sealed.",
   "title": "As-of depth"
  },
  {
   "id": "sources",
   "text": "12 source pages are named on this page; every value above carries its own source page and read date in the numbers.",
   "title": "Sources"
  }
 ],
 "sources": [
  {
   "for": "identity.exchange",
   "source": "https://www.londonstockexchange.com/live-markets/market-data-dashboard/price-explorer"
  },
  {
   "for": "identity.isin",
   "source": "https://api.londonstockexchange.com/api/gw/lse/instruments/alldata/SVNS"
  },
  {
   "for": "identity.jurisdiction",
   "source": "https://find-and-update.company-information.service.gov.uk/company/10776788"
  },
  {
   "for": "identity.lei",
   "source": "https://mapping.gleif.org/api/v2/isin-lei/latest/download"
  },
  {
   "for": "identity.sector",
   "source": "https://www.londonstockexchange.com/stock/SVNS/solvonis-therapeutics-plc/company-page"
  },
  {
   "for": "the disclosure lines",
   "source": "https://mcp.uk-cm-kg.ai/events/LSE/SVNS"
  },
  {
   "for": "the halt flag",
   "source": "https://marketsecurities.fca.org.uk/officiallist"
  },
  {
   "for": "the auditor",
   "source": "https://find-and-update.company-information.service.gov.uk/company/10776788/filing-history/MzUyMzcxNjc5NWFkaXF6a2N4/document?format=pdf&download=0"
  },
  {
   "for": "the orderability chapter",
   "source": "https://mcp.uk-cm-kg.ai/book/aio.json"
  },
  {
   "for": "coverage",
   "source": "https://solvonis.com/investor-relations/analyst-coverage"
  },
  {
   "for": "open research",
   "source": "https://cdn.smartinsider.com/InternalAnnouncement/pdf/2026/07/13/47627131.pdf"
  },
  {
   "for": "the record",
   "source": "https://mcp.uk-cm-kg.ai/record/LSE/SVNS"
  }
 ],
 "title": "SOLVONIS THERAPEUTICS PLC (SVNS) — research page",
 "writer": {
  "by": "Claude through the platform account, Haiku class; one pass; checked against the numbers",
  "engine": "claude-haiku-5-5"
 }
}